AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glyril M 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Ajapa Pharma Private Limited

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glyril M 1mg/500mg Tablet SR

Diabex Duo 1mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer Diabex Duo with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical supervision risks elevated glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan encompassing a healthy diet, regular physical activity, and weight management as recommended by your doctor. Lifestyle choices significantly impact diabetes control. The most frequent adverse effect is hypoglycemia (low blood sugar). Learn to identify symptoms like sweating, dizziness, headache, and tremors, and know how to manage them. Regular meals and carrying a fast-acting glucose source (e.g., sugary snacks or juice) are crucial preventative measures. Alcohol consumption should be minimized due to increased hypoglycemia risk. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur in some patients. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney impairment. Individuals with a history of heart disease should inform their doctor before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is essential, and your physician may order blood tests to assess blood cell counts and liver function.

Uses of Glyril M 1mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glyril M 1mg/500mg Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to the advised dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Glyril M 1mg/500mg Tablet SR with a meal.

Common Side effects of Glyril M 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glyril M 1mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or breaking it. The Glyril M 1mg/500mg Sustained-Release tablet should be administered with food.

How Glyril M 1mg/500mg Tablet SR works:

Glyril M SR tablets (1mg/500mg) contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use and Glyril M 1mg/500mg SR tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glyril M 1mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. Prescribing will be based on a risk-benefit assessment by your physician. Seek medical advice before using this medication.

Breast feedingBreast feedingUNSAFE

Extended-release Glyril M tablets (1mg/500mg) are contraindicated for breastfeeding mothers due to potential infant toxicity.

DrivingDrivingCAUTION

Impaired driving is a possibility if your blood glucose levels are either excessively low or elevated. Refrain from driving if you experience such symptoms.

KidneyKidneyCAUTION

Patients with impaired kidney function should exercise caution when using Glyril M 1mg/500mg SR tablets, as dosage modification may be necessary. Consult your physician for guidance. Glyril M 1mg/500mg SR tablets are contraindicated in individuals with severely compromised kidney function. Close monitoring of renal parameters is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glyril M 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician. Low initial doses are typically prescribed for those with mild to moderate hepatic dysfunction; however, Glyril M 1mg/500mg SR tablets are contraindicated in cases of severe liver disease.

What if you forget to take Glyril M 1mg/500mg Tablet SR :

Should you forget to take your Glyril M 1mg/500mg Tablet SR, administer it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glyril M 1mg/500mg Tablet SR

LabelValue
Addictive None.
Medication Classification Diabetes medication

FAQs on Glyril M 1mg/500mg Tablet SR

Store this medication in its original, tightly sealed container or packaging, following all storage instructions provided on the label. Discard any leftover medication. Prevent access by children, pets, and others.
Glyril M 1mg/500mg Tablet SR can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare but potentially harmful side effect is more likely in individuals with impaired kidney function, the elderly, or those who consume substantial alcohol. Symptoms may involve muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, or bradycardia. Should these symptoms appear, discontinue Glyril M 1mg/500mg Tablet SR and seek immediate medical attention.
Glyril M 1mg/500mg Extended-Release Tablets contain glimepiride and metformin, two medications used together to manage type 2 diabetes. This treatment improves blood sugar control in adults when combined with a healthy diet and regular physical activity. Glimepiride enhances insulin secretion from the pancreas, thus reducing blood glucose. Metformin reduces hepatic glucose production and increases insulin sensitivity. This dual-medication approach is unsuitable for treating type 1 diabetes.
Taking Glyril M 1mg/500mg Extended-Release Tablets may cause frequent side effects including low blood sugar, taste changes, queasiness, abdominal discomfort, loose stools, and headaches. Rare but potentially severe adverse reactions such as lactic acidosis are also possible. Prolonged use might result in Vitamin B12 deficiency.
Prolonged Glyril M 1mg/500mg Tablet SR use can indeed lead to Vitamin B12 deficiency. This medication disrupts Vitamin B12 absorption within the gastrointestinal tract. Untreated deficiency may result in anemia, neurological complications such as paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive impairment, and ataxia. Preventive strategies proposed by some studies include annual supplemental Vitamin B12 administration.
Glyril M 1mg/500mg SR tablets can induce hypoglycemia. Low blood sugar symptoms encompass nausea, headache, irritability, hunger, sweating, dizziness, tachycardia, and feelings of anxiety or tremor. The risk increases with missed or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, regular blood glucose monitoring is crucial. Carrying a readily available fast-acting sugar source, such as glucose tablets, honey, or fruit juice, is recommended.
Consuming alcohol concurrently with Glyril M 1mg/500mg SR tablets is inadvisable due to the risk of hypoglycemia from reduced blood sugar and a heightened probability of lactic acidosis.
Glyril M 1mg/500mg Tablet...
46
MRP 56
17% off